UL Solutions Inc.
ULS
$73.31
-1.45%
UL Solutions Inc. is a global leader in testing, inspection, and certification (TIC) services, operating primarily through Industrial and Consumer segments that together account for the vast majority of revenue, complemented by a smaller Risk & Compliance Software and advisory business. Spun off from the broader UL Enterprise and listed on the NYSE in April 2024, the company occupies a distinctive position as a mission-critical safety and compliance gatekeeper for manufacturers, with a trusted brand and regulatory-entrenched moat that differentiates it from pure-play testing peers. The current investor narrative centers on a sharp post-earnings de-rating: despite a solid second-quarter 2026 print with 5.15% revenue growth and a 30.1% net margin, the stock has fallen roughly 20% over six months and sits near the bottom of its 52-week range, prompting debate over whether the selloff reflects transient margin/working-capital noise or a structural slowdown in industrial demand. Bulls point to resilient organic growth, expanding gross margins, and a fortress balance sheet with declining leverage, while bears highlight decelerating momentum, a rich absolute valuation, and the stock's persistent underperformance versus the broader market.…
ULS
UL Solutions Inc.
$73.31
Investment Opinion: Should I buy ULS Today?
Rating: Hold. The core thesis is that UL Solutions is a high-quality, mission-critical TIC provider with a regulatory moat and solid margins, but the current valuation (forward PE of 28.2x) already reflects much of the recovery optimism, and the stock lacks a near-term catalyst to reverse its downtrend. The analyst consensus of 'buy' with an average target of $96.57 (31.7% upside) suggests the Street is more constructive, but the wide target range ($79-$120) and mixed institutional actions (UBS upgrade, but Citi and JPM Neutral) warrant caution.
Supporting evidence includes: 1) Gross margin expansion to 51.1% from 49.0% YoY, 2) Operating margin stable at 18.4%, 3) Debt-to-equity reduced to 0.659 from over 1.0, and 4) Free cash flow TTM of $436 million (2.75% yield). However, revenue growth of 5.15% is below the sector average, and the trailing PE of 48.7x is in the upper half of its historical range (20.9x-59.7x), leaving little room for error. The forward PE of 28.2x implies earnings growth of 42%, which is ambitious given the modest top-line trajectory.
Risks that could invalidate the thesis include a continued deceleration in industrial demand, margin pressure from wage inflation, and a breakdown below the 52-week low of $63.17. The rating would upgrade to Buy if the stock pulls back to the $65-$70 range (forward PE ~23-24x) or if revenue growth accelerates above 8%. It would downgrade to Sell if gross margins fall below 48% or if forward EPS estimates are cut by more than 10%. Relative to its history and peers, the stock is fairly valued to slightly overvalued, with the premium justified only by its brand and ROE of 25.8%.
Sign up to view all
ULS 12-Month Price Forecast
The forward-looking view is balanced: UL Solutions is a high-quality franchise with a regulatory moat and strong margins, but its growth is too slow to support a premium multiple without a catalyst. The stock's 20% decline has improved the risk/reward, but the downtrend and high short interest suggest caution. I would upgrade to bullish if revenue growth accelerates above 7% and gross margins hold above 51%, or if the stock pulls back to $65 (forward PE ~23x). I would downgrade to bearish if operating margins fall below 17% or if forward EPS estimates are cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on UL Solutions Inc.'s 12-month outlook, with a consensus price target around $96.57 and implied upside of +31.7% versus the current price.
Average Target
$96.57
0 analysts
Implied Upside
+31.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$79 - $120
Analyst target range
Coverage is solid with 12 analysts, and the consensus recommendation is "buy" with a mean rating of 1.85 (where 1 is strong buy), indicating a bullish tilt. The average target price of $96.57 implies roughly +31.7% upside from the current $73.31, a wide gap that reflects analysts' view that the selloff is overdone relative to fundamentals. Consensus EPS of $2.88 and revenue of $3.72 billion for the forward period support the constructive stance, and the buy-leaning distribution suggests the Street sees the current price as a dislocation rather than a value trap. The target range spans $79.00 to $120.00, a spread of roughly 52% of the current price that signals meaningful uncertainty; the high target of $120 assumes multiple re-expansion toward historical peaks alongside accelerating software/advisory mix and margin recovery, while the low target of $79 (still +7.8% above spot) prices in continued industrial softness but no catastrophic deterioration. Institutional actions show a modestly constructive drift: UBS upgraded to Buy from Neutral in July 2026, Baird reiterated Outperform in September, and Wells Fargo has maintained Overweight, while Citigroup and JP Morgan remain Neutral—suggesting the bull case is gaining traction but not yet universal. The tight clustering of low targets above the current price is a notable signal that even the bear case sees limited downside from here.
Bulls vs Bears: ULS Investment Factors
The bear case currently has stronger evidence due to the persistent downtrend, premium valuation, and decelerating growth, but the bull case is gaining traction with analyst targets implying significant upside and a fortress balance sheet. The most important tension is whether the recent margin expansion and low-beta resilience can translate into sustained earnings growth to justify the forward PE of 28.2x, or whether industrial demand remains too soft to support multiple re-expansion. The stock's 20% six-month decline has compressed the multiple, but it still trades at a premium to peers, leaving limited margin of safety. A clear catalyst—such as a reacceleration in organic growth or a major contract win—is needed to break the negative momentum.
Bullish
- Analyst consensus sees 31.7% upside: The average analyst target price of $96.57 implies a 31.7% gain from the current $73.31, with a 'buy' consensus rating (mean 1.85) from 12 analysts. Even the lowest target of $79 sits 7.8% above the current price, suggesting the Street views the selloff as overdone.
- Gross margins expanding, profitability solid: Q2 2026 gross margin rose to 51.1% from 49.0% a year earlier, and operating margin held at 18.4% despite revenue growth of only 5.15%. The underlying business remains highly profitable with a 17.1% TTM operating margin and 25.8% ROE.
- Fortress balance sheet with deleveraging: Debt-to-equity has fallen to 0.659 from over 1.0 in 2024, interest coverage is roughly 30x, and the current ratio of 1.32 provides ample liquidity. Free cash flow TTM of $436 million comfortably covers $69 million of capex and $29 million of dividends.
- Low beta and oversold technical bounce: Beta of 0.707 means the stock is 29% less volatile than the market, yet it has bounced 14.3% in the past month off the September low of $63.17. The 1-month relative strength of +13.06% versus SPY's +1.22% signals improving short-term momentum.
Bearish
- Severe downtrend and relative underperformance: The stock is down 20.1% over six months and 16.5% over three months, with a max drawdown of -38.96% from its 52-week high of $107.54. It trades at just 23% of its 52-week range, and 1-year relative strength of -19.6% versus SPY's +15.5% highlights a massive structural lag.
- Rich valuation despite price decline: Trailing PE of 48.7x and forward PE of 28.2x represent a 30-50% premium to the specialty business services sector average in the high-teens to low-20s. EV/EBITDA of 23.7x and P/B of 12.56x are also elevated, leaving little room for disappointment.
- Decelerating revenue growth: Q2 2026 revenue grew only 5.15% YoY to $816 million, a modest pace that is insufficient to justify a premium multiple on its own. Sequential revenue has been stagnant around $758-$816 million, and the small Risk & Compliance Software segment at $52 million is not yet large enough to accelerate overall growth.
- Earnings quality concerns from one-time gain: Q2 2026 net income of $246 million was inflated by a $188 million other-income line, boosting pre-tax income to $338 million. Excluding this, operating income was $150 million, and the 30.1% net margin is not representative of ongoing profitability.
ULS Technical Analysis
ULS is in a sustained downtrend that has erased most of its post-IPO gains, with a 1-year price change of -4.08% masking a far more damaging path from the April 2026 highs near $104.89 to the current $73.31. The stock is trading at approximately 23% of its 52-week range (low of $63.17, high of $107.54), a positioning that signals persistent distribution and momentum breakdown rather than a healthy pullback; the -38.96% max drawdown underscores how severe the correction has been. This is a falling-knife setup where value-oriented buyers must demand either a confirmed base or a clear catalyst before stepping in. Recent momentum is bifurcated: the 1-month change of +14.28% shows a sharp counter-trend bounce off the September lows near $64, yet the 3-month change of -16.47% and 6-month change of -20.07% confirm the intermediate trend remains firmly negative. The 1-month relative strength of +13.06% versus SPY's +1.22% indicates the bounce is genuine short-term outperformance, but the 1-year relative strength of -19.61% versus SPY's +15.53% reveals a massive structural lag; this divergence typically signals either an early trend reversal attempt or a violent bear-market rally within a larger downtrend. Key levels are well defined: support sits at the 52-week low of $63.17, and a breakdown below that would likely trigger another leg of momentum selling, while resistance rests at the $107.54 high, with intermediate overhead near the $85-$90 zone where the stock repeatedly failed in July and August. A beta of 0.707 means the stock is roughly 29% less volatile than the market, which argues for larger position sizing tolerance but also means the stock will not powerfully rebound on broad market rallies; the recent bounce from $64 to $74.39 (+16% in roughly a month) demonstrates that low beta does not preclude sharp idiosyncratic moves when sentiment shifts.
Beta
0.71
0.71x market volatility
Max Drawdown
-39.0%
Largest decline past year
52-Week Range
$63-$108
Price range past year
Annual Return
-4.1%
Cumulative gain past year
| Period | ULS Return | S&P 500 |
|---|---|---|
| 1m | +14.3% | +0.2% |
| 3m | -16.5% | +2.9% |
| 6m | -20.1% | +8.4% |
| 1y | -4.1% | +14.9% |
| ytd | -9.4% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ULS Fundamental Analysis
Revenue is growing but decelerating: Q2 2026 revenue of $816 million represents 5.15% YoY growth versus $776 million in Q2 2025, a modest pace that nonetheless marks an acceleration from the prior-year comparison. The multi-quarter trajectory shows sequential stability ($758M in Q1 2026, $789M in Q4 2025, $783M in Q3 2025) with YoY growth in the mid-single digits, and segment data reveals Industrial at $402 million and Consumer at $362 million as the twin engines, with Risk & Compliance Software at just $52 million representing a small but higher-margin growth vector. The investment case hinges on whether TIC demand can reaccelerate as industrial capex cycles turn, since 5% organic growth is insufficient to justify a premium multiple on its own. Profitability is robust and improving: Q2 2026 net income of $246 million produced a 30.1% net margin, up dramatically from 11.7% in Q2 2025, though this quarter benefited from a $188 million other-income line that inflated pre-tax income to $338 million. Gross margin expanded to 51.1% from 49.0% a year earlier, and operating margin held at 18.4%, consistent with the 17.1% TTM operating margin; the underlying business is solidly profitable with gross margins near 50%, typical for asset-light TIC operators. The balance sheet is healthy and deleveraging: debt-to-equity of 0.659 has fallen from over 1.0 in 2024, the current ratio of 1.32 provides adequate liquidity, and interest coverage of roughly 30x in the latest quarter reflects minimal financial strain. Free cash flow TTM of $436 million against a $15.85 billion market cap yields about 2.75%, and quarterly FCF of $91 million comfortably funds $69 million of capex and $29 million of dividends, while ROE of 25.8% and ROA of 12.3% confirm efficient capital deployment.
Quarterly Revenue
$816000000.0B
2026-06
Revenue YoY Growth
+5.1%
YoY Comparison
Gross Margin
51.1%
Latest Quarter
Free Cash Flow
$436000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ULS Overvalued?
Because ULS is profitable (net income of $246 million in Q2 2026 and positive TTM EPS), the PE ratio is the appropriate primary metric: the trailing PE of 48.7x is elevated, but the forward PE of 28.2x implies the market expects earnings to roughly double, consistent with consensus EPS of $2.88 versus the current trailing figure. That 42% compression between trailing and forward multiples signals the market is pricing in meaningful margin normalization and growth, making the forward multiple the more relevant anchor for valuation. On a peer basis, the PS ratio of 5.19x and EV/Sales of 4.80x sit at a premium to typical specialty business services multiples, while the EV/EBITDA of 23.7x and P/B of 12.56x are rich; the forward PE of 28.2x versus a sector average in the high-teens to low-20s implies a roughly 30-50% premium that is only partially justified by UL's brand moat and 25.8% ROE. The PEG ratio of -79.3 is distorted by negative growth comparisons and should be disregarded. Historically, ULS's PE has ranged from roughly 20.9x (Q2 2026) to 59.7x (Q4 2025), and its PS ratio has ranged from 10.2x to 25.1x; the current PS of 5.19x appears low only because the historical series reflects a different share-count/market-cap basis, but the trailing PE of 48.7x sits in the upper half of its own band, suggesting the market still prices optimistic expectations despite the price decline. The stock is not cheap on absolute measures; the de-rating has been driven by multiple compression from peak levels rather than by earnings deterioration.
PE
48.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 19x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
23.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: UL Solutions carries a debt-to-equity of 0.659, which, while improved from over 1.0 in 2024, still represents a meaningful leverage burden relative to its $15.85 billion market cap. The Q2 2026 net margin of 30.1% was artificially boosted by a $188 million other-income gain; excluding this, the operating margin was 18.4%, and net income would have been closer to $150 million, highlighting earnings volatility. Revenue growth of 5.15% YoY is modest and heavily dependent on the Industrial segment ($402 million) and Consumer segment ($362 million), which together account for 93.6% of revenue, leaving the company vulnerable to cyclical downturns in manufacturing and consumer spending. Free cash flow TTM of $436 million yields only 2.75% of market cap, and while it covers capex and dividends, any margin compression could quickly strain cash generation.
Market & Competitive Risks: The stock trades at a trailing PE of 48.7x and forward PE of 28.2x, a 30-50% premium to the specialty business services sector, which exposes it to valuation compression if growth disappoints. Beta of 0.707 indicates lower market correlation, but the stock has still suffered a -38.96% max drawdown, showing it is not immune to sector rotation or macro headwinds. Competitive disruption from digital testing platforms or in-house certification could erode UL's moat, though no immediate threat is evident. Recent news is absent, but the stock's -19.6% 1-year relative strength versus SPY suggests persistent negative sentiment that could worsen if industrial capex slows further.
Worst-Case Scenario: A combination of a global industrial recession, margin compression from pricing pressure, and a failed product launch or regulatory setback could drive the stock to its 52-week low of $63.17, representing a 13.8% decline from the current $73.31. If the bear case fully materializes and the stock breaks below $63.17, the next support could be the IPO-era lows near $50, implying a 31.8% loss. The analyst low target of $79 is above the current price, but in a severe downturn, the stock could overshoot to the downside, as evidenced by the -38.96% max drawdown from the 52-week high.
FAQ
The key risks include: 1) Financial risk from a debt-to-equity of 0.659 and earnings volatility, as Q2 2026 net income was inflated by a one-time gain; 2) Competitive risk from digital disruption or insourcing by major customers; 3) Macro risk from an industrial slowdown, given 93.6% revenue concentration in Industrial and Consumer segments; and 4) Valuation risk, as the stock trades at a premium multiple that could compress if growth disappoints. The most severe is a breakdown below the 52-week low of $63.17, which could trigger further selling.
The 12-month forecast has three scenarios: bull case (25% probability) with a target range of $96.57-$120, base case (55% probability) with a range of $79-$96.57, and bear case (20% probability) with a range of $63.17-$79. The base case is most likely, assuming steady 5-6% revenue growth and stable margins, leading the stock toward the analyst average target of $96.57. The key assumption is that industrial demand does not deteriorate further and that the company meets consensus EPS of $2.88.
ULS appears slightly overvalued on absolute metrics, with a trailing PE of 48.7x and forward PE of 28.2x, both at a premium to the specialty business services sector. However, the forward PE is more reasonable given expected earnings growth, and the stock's 20% decline has compressed the multiple from peak levels. Compared to its own history, the trailing PE is in the upper half of its range (20.9x-59.7x), suggesting the market still prices optimistic expectations. The stock is fairly valued to slightly overvalued, with the premium justified only by its brand and high ROE.
ULS is a good buy for long-term investors who believe in the resilience of the TIC industry and are willing to tolerate near-term volatility. The analyst average target of $96.57 implies 31.7% upside, and the stock trades at a forward PE of 28.2x, which is a premium but supported by a 25.8% ROE and a regulatory moat. However, the biggest downside risk is a breakdown below the 52-week low of $63.17, which would represent a 13.8% loss from current levels. For risk-averse investors, waiting for a confirmed base or a catalyst is prudent.
ULS is more suitable for long-term investment (minimum 2-3 years) given its low beta of 0.707, stable dividend yield of 0.66%, and mission-critical business model. The stock's recent volatility and downtrend make it less attractive for short-term trading, although the 14.3% one-month bounce shows potential for tactical trades. Earnings visibility is moderate, with analyst estimates for revenue of $3.72 billion and EPS of $2.88, but the lack of a near-term catalyst suggests patience is required. A holding period of at least 2 years allows time for industrial cycles to recover and for the software segment to scale.